Newly discovered antibiotic class, Odilorhabdins, and how they work

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics. The antibiotic, first identified by Nosopharm, is unique and promising on two fronts: its unconventional source and its distinct way of killing ["]

The post Newly discovered antibiotic class, Odilorhabdins, and how they work appeared first on Outbreak News Today.